Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
407.6 EUR | -0.54% |
|
+1.34% | +10.39% |
Jun. 07 | Russian court orders $56 mln Landesbank Baden-Wuerttemberg asset seizure | RE |
May. 30 | ESAB to Acquire Linde Industries Private in Bangladesh for Undisclosed Sum | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 31.3 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+10.39% | 210B | - | ||
+24.63% | 12.95B | B | ||
+64.32% | 9.46B | C+ | ||
-15.78% | 3.34B | D+ | ||
+11.58% | 3.12B | C- | ||
+13.85% | 3.07B | C+ | ||
+10.72% | 2.29B | - | ||
-9.91% | 2.24B | - | ||
+3.96% | 1.66B | - | - | |
-22.42% | 1.24B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- LIN Stock
- LIN Stock
- Ratings Linde plc